First,to understand the present situation!: Transcutaneous aortic valve implantation as a real global treatment for severe aortic stenosis

Abstract

Get full access to this article

View all access options for this article.

References

Mack

Leon

Smith

et al.

5-Year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385: 2477–2484.

Kapadia

Leon

Makkar

et al.

5-Year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385: 2485–2491.

Baumgartner

Falk

Bax

et al.

2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38: 2739–2791.

Kodali

Thourani

White

et al.

Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J 2016; 37: 2252–2262.

Eggebrecht

Mehta

. Transcatheter aortic valve implantation (TAVI) in Germany 2008–2014: on its way to standard therapy for aortic valve stenosis in the elderly? EuroIntervention 2016; 11: 1029–1033.

de Brito

Jr Carvalho

Sarmento-Leite

et al.

Outcomes and predictors of mortality after transcatheter aortic valve implantation: results of the Brazilian registry. Catheteriz Cardiovasc Interven 2015; 85: E153–E162.

Escarcega

Lipinski

Baker

et al.

Analysis of long-term survival following transcatheter aortic valve implantation from a single high-volume center. Am J Cardiol 2015; 116: 256–263.

Mabin

Condolfi

. An analysis of real-world cost-effectiveness of TAVI in South Africa. Cardiovasc J Afr 2014; 25: 21–26.

Hon

JKF

Tay

. Transcatheter aortic valve implantation in Asia. Ann Cardiothorac Surg 2017; 6: 504–549.

10.

Rodes-Cabau

Webb

Cheung

et al.

Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol 2012; 60: 1864–1875.

11.

Takimoto

Saito

Minakata

et al.

Favorable clinical outcomes of transcatheter aortic valve implantation in Japanese patients – first report from the Post-Approval K-TAVI Registry. Circ J 2016; 81: 103–109.

12.

Subban

Murdoch

Savage

et al.

Outcomes of transcatheter aortic valve implantation in high surgical risk and inoperable patients with aortic stenosis: a single Australian Centre experience. Intern Med J 2016; 46: 42–51.

13.

Asteggiano

Bramlage

Richter

. European Society of Cardiology Council for Cardiology Practice worldwide survey of transcatheter aortic valve implantation beliefs and practices. Eur J Prev Cardiol 2018; 25: 608–617.

14.

Cribier

Eltchaninoff

Bash

et al.

Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106: 3006–3008.

15.

Kainuma

Kuratani

Shimamura

et al.

Transcatheter aortic valve implantation: first trans-iliac experience in Japan. Gen Thorac Cardiovasc Surg 2011; 59: 273–276.